MedTrace Logo

Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure

NCT06039553 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-09-15

No results posted yet for this study

Summary

The goal of this observational study is to learn about the safety and effectiveness of pulmonary artery banding(PAB) therapy in pediatric heart failure(PHF) patients.

The main questions it aims to answer are:

* Can PAB therapy improve left ventricular(LV) function in PHF patients especially refractory PHF.
* Can the complications caused by the PAB therapy be clinically acceptable? Participants underwent PAB therapy will be required to underwent echocardiography, electrocardiograms, complete blood counts, biochemical tests, and measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP) follow-up before the initiation of PAB and at 1 month, 3 months, and 6 months after PAB surgery. Researchers will compare the LV function 6 months after PAB suergey and the preoperative ones to see if there is improvement.

Conditions

  • Heart Failure Congenital

Interventions

PROCEDURE

pulmonary artery banding

Patient in this group will undergo pulmonary artery banding surgery for congenital heart disease.

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Beijing Children's Hospital

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Shoujun Li, MD · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-09-01
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06039553 on ClinicalTrials.gov